Stacked newspapers

Newsroom

NASTAD In the News

What is xylazine, and how is it contributing to overdose deaths?

Mar 28, 2023

An Evaluation of the Successes of the NASTAD Minority Leadership Program and Its Implications for Leadership in State Health Departments

Mar 24, 2023

Emory Launches Program to Deliver 1 Million Rapid HIV Self-tests Across the Country

Mar 21, 2023

Blog

Strengthening Immunization Efforts: NASTAD's Partnership with CDC for National Immunization Awareness Month and Back to School Campaign

Portrait of a little boy with a bandage on his arm after an injection

Aug 29, 2023

CDC Issues 2021 Viral Hepatitis Surveillance Report

Hepatitis B Virus

Aug 23, 2023

Enhancing Harm Reduction and PrEP/PEP Services Through Community Pharmacies

Aug 17, 2023

NASTAD Recommendations for Cluster and Outbreak Detection and Response & Molecular HIV Surveillance

Aug 2, 2023

See all blog posts

Press Releases

New Assessment Highlights Legal Authority of Pharmacists to Provide Access to Vital HIV and Harm Reduction Services Across U.S.

NASTAD Press Release

Aug 17, 2023

NASTAD Condemns LHHS Appropriations Bill that Would Cut Millions from Vital HIV/AIDS Prevention and Treatment Programs

Photo of U.S. Congress

Jul 14, 2023

NASTAD Awards $6 Million to Syringe Services Programs (SSPs) and Harm Reduction Organizations

Apr 7, 2023

End of Mandatory Coverage of PrEP by Insurers Puts Lives at Risk

Mar 31, 2023

See all press releases

Newsletters

Ending the HIV Epidemic Newsletter

Newsletter: EHE

Sep 26, 2023

Policy Updates: Hill Happenings and Administration Activities

Newsletter: Policy

Sep 25, 2023

Hepatitis Happenings and Updates

Sep 25, 2023

Policy Updates: Hill Happenings and Administration Activities

Sep 18, 2023

See all newsletters

Press Contact

Kyle Taylor

NASTAD
444 North Capitol Street NW
Suite 339
Washington, DC 20001

press@NASTAD.org

NASTAD Logos

Download Logo Files